Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Katsuki Sugiyama"'
Autor:
Kazuhito Suzuki, Shingo Yano, Kaichi Nishiwaki, Koji Sano, Takaki Shimada, Yuichi Yahagi, Yoji Ogasawara, Katsuki Sugiyama, Shinobu Takahara, Takeshi Saito, Kinuyo Kasama, Jiro Minami, Hiroki Yokoyama, Yutaro Kamiyama, Atsushi Katsube, Hidekazu Masuoka, Mitsuji Katori, Tomohito Machishima, Aya Ouchi, Nobuaki Dobashi, Ken Kaito, Noriko Usui, Keisuke Aiba
Publikováno v:
Cancer Medicine, Vol 5, Iss 11, Pp 3051-3058 (2016)
Abstract The clinical features and prognostic significance of myeloma cells containing granules remain unclear. The purpose of this retrospective study was to investigate the clinical significance of granule‐containing myeloma cells in patients wit
Externí odkaz:
https://doaj.org/article/2620492b797f4764b73082a649898233
Autor:
Rachel B Munk, Katsuki Sugiyama, Paritosh Ghosh, Carl Y Sasaki, Louis Rezanka, Kasturi Banerjee, Hidenori Takahashi, Ranjan Sen, Dan L Longo
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e18553 (2011)
The role of T cells in innate immunity is not well defined. In this report, we show that a subset of human peripheral blood CD4(+) T cells responds to IL-12 plus IL-18, but not to IL-12 or IL-18 alone, by producing IFN-γ in the absence of any antige
Externí odkaz:
https://doaj.org/article/e66d1bc13d5a4f439759c52e84132641
Autor:
Noriko Usui, Kazuhito Suzuki, Yoji Ogasawara, Jiro Minami, Nobuaki Dobashi, Atsushi Katsube, Keisuke Aiba, Shingo Yano, Katsuki Sugiyama, Shinobu Takahara, Tomohito Machishima, Takaki Shimada, Masaharu Kawashima, Yutaro Kamiyama, Yuichi Yahagi, Takeshi Saito, Hiroki Yokoyama
Publikováno v:
Journal of Hematopoietic Cell Transplantation. 7:9-16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8db3f06e584abfd7bda8dd4fd9008f83
https://doi.org/10.7889/hct-17-002
https://doi.org/10.7889/hct-17-002
Autor:
Yutaro Kamiyama, Yuichi Yahagi, Hiroki Yokoyama, Katsuki Sugiyama, Shingo Yano, Takeshi Saito, Kazuhito Suzuki, Noriko Usui, H Masuoka, Mitsuji Katori, Koji Sano, Shinobu Takahara, Nobuaki Dobashi, Yoji Ogasawara, Kaichi Nishiwaki, Ken Kaito, Aya Ouchi, Tomohito Machishima, Kinuyo Kasama, Jiro Minami, Atsushi Katsube, Keisuke Aiba, Takaki Shimada
Publikováno v:
Cancer Medicine, Vol 5, Iss 11, Pp 3051-3058 (2016)
Cancer Medicine
Cancer Medicine
The clinical features and prognostic significance of myeloma cells containing granules remain unclear. The purpose of this retrospective study was to investigate the clinical significance of granule‐containing myeloma cells in patients with newly d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca10f70e79f85550e518bcd0677d2695
https://doaj.org/article/2620492b797f4764b73082a649898233
https://doaj.org/article/2620492b797f4764b73082a649898233
Autor:
Yasuyuki Nakada, Ai Katsuma, Ichiro Ohkido, Nobuo Tsuboi, Yo Komatsuzaki, Yoji Ogasawara, Takaki Shimada, Mayuko Kawabe, Yudo Tanno, Akihiro Shimizu, Takashi Yokoo, Katsuki Sugiyama, Keisuke Aiba, Kazuhito Suzuki, Izumi Yamamoto, Naomi Hayashi
Publikováno v:
CEN Case Reports. 5:232-237
Myeloma cast nephropathy is a major complication of multiple myeloma. Recent evidence has demonstrated that the earlier induction of bortezomib-based chemotherapy with plasma exchange (PE) provides better results for kidney function and patient survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63108f6c10028ed4945d9317fe2b3161
https://doi.org/10.1007/s13730-016-0231-4
https://doi.org/10.1007/s13730-016-0231-4
Autor:
Shinobu Takahara, Yutaro Kamiyama, Yuichi Yahagi, Kazuhiro Kondo, Atsushi Katsube, Kazuhito Suzuki, Hiroyuki Yanagisawa, Keisuke Aiba, Shingo Yano, Takeshi Saito, Jiro Minami, Nobuyuki Kobayashi, Yoji Ogasawara, Katsuki Sugiyama, Hiroki Yokoyama, Takaki Shimada
Publikováno v:
International journal of hematology. 108(6)
Cancer-related fatigue (CRF) is one of the adverse events in multiple myeloma (MM) patients treated with cytotoxic agents, proteasome inhibitors (PIs), and immunomodulatory drugs (IMiDs) such as bortezomib, lenalidomide, and thalidomide. The aims of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1870df8f99ae6d6e30326325face18b9
https://pubmed.ncbi.nlm.nih.gov/30155589
https://pubmed.ncbi.nlm.nih.gov/30155589
Autor:
Shinobu Takahara, Yutaro Kamiyama, Yuichi Yahagi, Kiyomi Mashima, Kazuhito Suzuki, Yoji Ogasawara, Katsuki Sugiyama, Hisashi Yamada, Atsushi Katsube, Keisuke Aiba, Sayaka Ohshima, Shingo Yano, Jiro Minami, Noriko Usui, Tomohito Machishima, Takaki Shimada, Hiroki Yokoyama, Takeshi Saito
Publikováno v:
Internal Medicine
Epstein-Barr virus (EBV)-associated lymphoproliferative disorders (LPDs) sometimes occur following Anti-thymocyte globulin (ATG) administration for allogenic stem cell transplantation but are rare in aplastic anemia (AA) patients. A 55-year-old woman
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa25146d180a065fd673bdd9a77d82bb
https://pubmed.ncbi.nlm.nih.gov/28321074
https://pubmed.ncbi.nlm.nih.gov/28321074
Autor:
Katsuki Sugiyama
Publikováno v:
Chemotherapy for Leukemia ISBN: 9789811033308
Rituximab is a chimeric anti-CD20 monoclonal antibody (mAb) and the first mAb to be approved for use in the treatment of cancer. The proposed mechanisms of action of rituximab include antibody-dependent cellular cytotoxicity (ADCC), complement-depend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::256dde78e6dca258edd9c28cfc9bbacd
https://doi.org/10.1007/978-981-10-3332-2_5
https://doi.org/10.1007/978-981-10-3332-2_5
Autor:
Noriko Usui, Keisuke Aiba, Katsuki Sugiyama, Shingo Yano, Takeshi Saito, Yutaka Takei, Shinobu Takahara, Nobuaki Dobashi
Publikováno v:
International Cancer Conference Journal. 1:37-40
We present a case involving a 53-year-old male with acute promyelocytic leukemia who developed retinoic acid syndrome (RAS) during leukopenia. He received all-trans retinoic acid (ATRA) therapy at a dose of 90 mg/day (45 mg/m2). On day 17, his fever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10aa654a6f81969a5858b4ed4a025e84
https://doi.org/10.1007/s13691-011-0006-x
https://doi.org/10.1007/s13691-011-0006-x
Autor:
Shingo Yano, Noriko Usui, Masayuki Kobayashi, Katsuki Sugiyama, Takeshi Saito, Kyoko Ueda, Mamoru Hisatomi, Nobuaki Dobashi, Osamu Asai
Publikováno v:
Internal Medicine. 44:145-148
A 17-year-old woman was diagnosed as acute lymphoblastic leukemia (ALL). As she had chromosomal abnormalities of 44, XO, der(9)t(3;9)(q11;p13), der(10;19)(q10;p10), del(15)(q15), -16, -19, +22 with the presence of ovarian dysplasia and abnormal physi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad214287b56b21b8e5611878b39eb26e
https://doi.org/10.2169/internalmedicine.44.145
https://doi.org/10.2169/internalmedicine.44.145